ctrl K

Watchlist Price Alert

Obalon Therapeutics Inc. (OBLN)

NASDAQ: OBLN · Real-Time Price · USD

3.05

-0.19 (-5.86%)

At close: Jun 16, 2021, 6:00 AM

Obalon Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	1.59M	3.28M	9.1M	9.91M	3.39M
Cost of Revenue	1M	2.95M	5.42M	4.83M	2.81M
Gross Profit	584K	331K	3.68M	5.08M	584K
Operating Income	-10.64M	-23.23M	-36.97M	-34.39M	-19.5M
Interest Income	n/a	n/a	n/a	n/a	n/a
Pretax Income	-12.33M	-23.68M	-37.38M	-34.77M	-20.47M
Net Income	-12.33M	-23.68M	-37.38M	-34.77M	-20.47M
Selling & General & Admin	8.78M	16.67M	29.95M	28.83M	10.22M
Research & Development	2.45M	6.89M	10.7M	10.65M	9.87M
Other Expenses	n/a	n/a	n/a	n/a	n/a
Operating Expenses	11.23M	23.56M	40.64M	39.48M	20.09M
Interest Expense	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	12.23M	26.51M	46.07M	44.3M	22.9M
Income Tax Expense	-1.69M	-446K	-415K	-374K	-962K
Shares Outstanding (Basic)	7.77M	4.71M	1.9M	1.67M	422.19K
Shares Outstanding (Diluted)	7.77M	4.71M	1.9M	1.67M	422.19K
EPS (Basic)	-1.59	-5.03	-19.64	-20.8	-48.48
EPS (Diluted)	-1.59	-5.03	-19.64	-20.8	-48.48
EBITDA	-11.49M	-22.78M	-36.8M	-34.44M	-20.27M
EBIT	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	843K	894K	581K	330K	192K